Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
If your budget isn’t sticking, you’re not alone. Here are common reasons budgets fail and simple adjustments you can make right away.
20,953 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
When the broader market fell, one name stood out. This article explains why plug power stock defied the downturn, fea...
XRP faces a pivotal test as a new AI-driven forecast hints at a multi-dollar rally by the end of 2026, even as the to...
A single cloud ETF has become the dominant vehicle for exposure as cloud stocks swing in 2026, prompting a shift away...
A new Nasdaq-100 strategy fund began paying weekly Friday distributions, targeting a 40% yield and challenging the tr...
A soon-to-retire investor outlines a simple, income-centric ETF strategy built around three funds—JEPQ, DIVO, and SPH...
A bipartisan Wisconsin panel has found probable cause that Elon Musk’s million offers to voters may violate state ele...
Gevo's 2025 earnings story hinges on SAF production, licensing deals, and cost management. This article breaks down t...
Stocks and exchange-traded funds tied to PayPal surged after Reuters reported Stripe and Advent International were we...
Even as oil prices swing widely, four energy dividend giants have kept their payouts steady and growing. This piece l...
ExxonMobil is not just drilling and refining anymore. This article explores how the company might evolve toward a bro...
Berkshire Hathaway disclosed a Domino's Pizza stake in late 2024, underscoring a focus on franchise-heavy, cash-gener...